BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26802648)

  • 1. Curcumin Enhances the Effects of 5-Fluorouracil and Oxaliplatin in Inducing Gastric Cancer Cell Apoptosis Both In Vitro and In Vivo.
    Zhou X; Wang W; Li P; Zheng Z; Tu Y; Zhang Y; You T
    Oncol Res; 2016 Jan; 23(1-2):29-34. PubMed ID: 26802648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Curcumin combined FOLFOX induced cell apoptosis of gastric cancer and its mechanism research].
    Zhou X; You T; Wang WM; Zheng ZQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):810-3. PubMed ID: 23980364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis.
    Guo LD; Shen YQ; Zhao XH; Guo LJ; Yu ZJ; Wang D; Liu LM; Liu JZ
    Phytother Res; 2015 Mar; 29(3):357-65. PubMed ID: 25418925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells.
    Genovese S; Epifano F; Preziuso F; Slater J; Nangia-Makker P; Majumdar APN; Fiorito S
    Biochem Biophys Res Commun; 2020 Jan; 522(1):95-99. PubMed ID: 31740005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.
    Patel BB; Sengupta R; Qazi S; Vachhani H; Yu Y; Rishi AK; Majumdar AP
    Int J Cancer; 2008 Jan; 122(2):267-73. PubMed ID: 17918158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suberoylanilide hydroxamic acid enhances the antitumor activity of oxaliplatin by reversing the oxaliplatin‑induced Src activation in gastric cancer cells.
    Zhou C; Ji J; Shi M; Yang L; Yu Y; Liu B; Zhu Z; Zhang J
    Mol Med Rep; 2014 Nov; 10(5):2729-35. PubMed ID: 25199623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Nukatsuka M; Nakagawa F; Takechi T
    Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells.
    Attoub S; Arafat K; Khalaf T; Sulaiman S; Iratni R
    Nutrients; 2018 May; 10(5):. PubMed ID: 29724012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro.
    Zhao Q; Zhang H; Li Y; Liu J; Hu X; Fan L
    J Exp Clin Cancer Res; 2010 Aug; 29(1):118. PubMed ID: 20799994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin derivative L6H4 inhibits proliferation and invasion of gastric cancer cell line BGC-823.
    Mu J; Wang X; Dong L; Sun P
    J Cell Biochem; 2019 Jan; 120(1):1011-1017. PubMed ID: 30242876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
    Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.
    Li L; Ahmed B; Mehta K; Kurzrock R
    Mol Cancer Ther; 2007 Apr; 6(4):1276-82. PubMed ID: 17431105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axitinib alone or in combination with chemotherapeutic drugs exerts potent antitumor activity against human gastric cancer cells in vitro and in vivo.
    He Q; Gao J; Ge S; Wang T; Li Y; Peng Z; Li Y; Shen L
    J Cancer Res Clin Oncol; 2014 Sep; 140(9):1575-83. PubMed ID: 24804814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y; Zhang M; Zhang Z; Jia Y; Zhang C; Peng L
    Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer.
    Zheng X; Yang X; Lin J; Song F; Shao Y
    Phytomedicine; 2021 May; 85():153547. PubMed ID: 33812170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection by Cx43 adenovirus increased chemotherapy sensitivity in human gastric cancer BGC-823 cells: not involving in induction of cell apoptosis.
    Liu D; Zhou H; Wu J; Liu W; Li Y; Shi G; Yue X; Sun X; Zhao Y; Hu X; Wang T; Zhang X
    Gene; 2015 Dec; 574(2):217-24. PubMed ID: 26318481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells.
    Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P
    Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice.
    Zhang P; Lai ZL; Chen HF; Zhang M; Wang A; Jia T; Sun WQ; Zhu XM; Chen XF; Zhao Z; Zhang J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):190. PubMed ID: 29273065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.